Li, T., Yao, W., Dong, H., Wang, Z., Zhang, Z., Yuan, M., . . . Wang, F. (2023). Plasma proteomics-based biomarkers for predicting response to mesenchymal stem cell therapy in severe COVID-19. Stem Cell Research & Therapy, 14(1), 1. https://doi.org/10.1186/s13287-023-03573-4
Chicago Style (17th ed.) CitationLi, Tian-Tian, Wei-Qi Yao, Hai-Bo Dong, Ze-Rui Wang, Zi-Ying Zhang, Meng-Qi Yuan, Lei Shi, and Fu-Sheng Wang. "Plasma Proteomics-based Biomarkers for Predicting Response to Mesenchymal Stem Cell Therapy in Severe COVID-19." Stem Cell Research & Therapy 14, no. 1 (2023): 1. https://doi.org/10.1186/s13287-023-03573-4.
MLA (9th ed.) CitationLi, Tian-Tian, et al. "Plasma Proteomics-based Biomarkers for Predicting Response to Mesenchymal Stem Cell Therapy in Severe COVID-19." Stem Cell Research & Therapy, vol. 14, no. 1, 2023, p. 1, https://doi.org/10.1186/s13287-023-03573-4.